Gamma Knife radiosurgery for relapsing trigeminal neuralgia following microvascular decompression
View abstract on PubMed
Summary
This summary is machine-generated.Salvage Gamma Knife radiosurgery (GKRS) effectively treats recurrent trigeminal neuralgia (TN) after microvascular decompression (MVD). Post-operative facial numbness and a good initial pain response predict longer-lasting relief, with a manageable complication rate.
Area Of Science
- Neurosurgery
- Radiation Oncology
- Pain Management
Background
- Trigeminal neuralgia (TN) is a debilitating neuropathic pain condition.
- Microvascular decompression (MVD) is a primary surgical treatment for TN.
- Recurrence of TN after MVD necessitates alternative treatment strategies.
Purpose Of The Study
- To evaluate the efficacy and safety of salvage Gamma Knife radiosurgery (GKRS) for TN patients with recurrent pain post-MVD.
- To determine the response rate, pain relief durability, and complication profile of salvage GKRS.
- To identify predictors of pain relapse after salvage GKRS.
Main Methods
- Retrospective analysis of patients with TN1 or TN2 who underwent salvage GKRS post-MVD.
- Pain assessment using the Barrow Neurological Institute (BNI) pain intensity score.
- Kaplan-Meier analysis for durability of pain relief and Cox regression for relapse predictors.
Main Results
- 83.1% of patients achieved initial pain relief (BNI scores I-III) after salvage GKRS.
- Median time to relapse was 1.75 years; 1, 2, and 5-year relapse-free rates were 77%, 45.9%, and 30.7%.
- Pre-MVD radiofrequency ablation decreased initial response; post-operative facial numbness and better initial pain response predicted durable relief.
Conclusions
- Salvage GKRS is an effective, noninvasive option for recurrent TN after MVD, offering comparable efficacy to primary treatments.
- The complication profile of salvage GKRS is favorable compared to repeat MVD.
- Facial numbness and a strong initial pain response are associated with more durable pain relief.

